Darling, AlejandraTello, CristinaMartí, María JosepGarrido, CristinaAguilera-Albesa, SergioTomás Vila, MiguelGastón, ItziarMadruga, MarcosGonzález Gutiérrez, LuisRamos Lizana, JulioPujol, MontserratGavilán Iglesias, TaniaTustin, KyleeLin, Jean PierreZorzi, GiovannaNardocci, NardoMartorell, LoretoLorenzo Sanz, GustavoGutiérrez, FuencislaGarcía, Pedro J.Vela, LidiaHernández Lahoz, CarlosOrtigoza Escobar, Juan DaríoMartí Sánchez, LauraMoreira, FradiqueCoelho, MiguelCorreia Guedes, LeonorCastro Caldas, AnaFerreira, JoaquimPires, PaulaCosta, CristinaRego, PauloMagalhães, MarinaStamelou, MaríaCuadras Pallejà, DanielRodríguez-Blazquez, CarmenMartínez-Martín, PabloLupo, VincenzoStefanis, LeonidasPons, RoserEspinós, CarmenTemudo, TeresaPérez Dueñas, Belén2021-01-112021-01-112017-08-28Movement Disorders, Vol. 32, No. 11, 2017, p 1620-16301531-8257http://hdl.handle.net/10400.26/34650Pantothenate kinase-associated neurodegeneration is a progressive neurological disorder occurring in both childhood and adulthood. The objective of this study was to design and pilot-test a disease-specific clinical rating scale for the assessment of patients with pantothenate kinase-associated neurodegeneration.engAdolescentAdultAgedChildCognitive DysfunctionCross-Sectional StudiesDystoniaHumansMental DisordersMiddle AgedOcular Motility DisordersPantothenate Kinase-Associated NeurodegenerationParkinsonian DisordersPilot ProjectsReproducibility of ResultsYoung AdultDisabled PersonsSeverity of Illness Indexjournal article10.1002/mds.27129